Objectives: to evaluate vitamin C supplementation in the prevention of isch
aemia-reperfusion il-Xi induced acute lung injury.
Design: Sprague-Dawley mts (n = 6/group) were randomised into Control, I-R
and I-X pretreated with vitamin C (3.3 g over 5 days). Ischaemia-reperfusio
n injury was induced by 30 minutes infrarenal aortic cross-clamping and 120
minutes reperfusion.
Methods: pulmonary microvascular injury was measured by broncho-alveolar la
vage protein concentration, pulmonary neutrophil infiltration by tissue mye
loperoxidase activity and bronchoalveolar lavage neutrophil counts. In a se
cond experiment (n = 5/group) neutrophil respiratory burst activity was mea
sured in Control and vitamin C groups.
Results: ischaemia-reperfusion resulted in a significant increase in both m
icrovascular leakage and pulmonary neutrophil infiltration as measured by b
ronchoalveolar lavage protein concentration and pulmonary myeloperoxidase a
ctivity respectively. Pretreatment with vitamin C significantly attenuated
both microvascular leakage and neutrophil infiltration. Neutrophil respirat
ory burst activity was significantly reduced in the vitamin C group (13.02
m.c.f. +/- 0.3) compared with Control (19.04 m.c.f. +/- 1.9), p<0.02.
Conclusion: these data suggest that oral vitamin C therapy protects against
ischaemia-reperfusion-induced acute lung injury, possibly by attenuating n
eutrophil respiratory burst activity.